Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Lachman

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1981
Human T lymphocyte/monocyte interaction in response to lectin: kinetics of entry into the S-phaseA L Maizel, S R Mehta, S Hauft, et al.
Cancer Gene Therapy|June 8, 2001
DNA vaccination against neu reduces breast cancer incidence and metastasis in miceL B Lachman, X M Rao, R H Kremer, et al.
Nature|November 19, 1981
Soluble factor activation of human B lymphocytesR J Ford, S R Mehta, D Franzini, et al.
Gene Therapy|October 7, 2006
Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasisM C Leslie, Y-J Zhao, L B Lachman, et al.
Helicobacter|February 15, 2000
Quantitation of Helicobacter pylori in the stomach using quantitative polymerase chain reaction assaysB Ozpolat, J K Actor, X M Rao, et al.
AIDS Research and Human Retroviruses|August 1, 1995
Cytokine-containing liposomes as adjuvants for HIV subunit vaccinesL B Lachman, L C Shih, X M Rao, et al.
The Journal of Experimental Medicine|October 1, 1983
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cellsE A Grimm, R J Robb, J A Roth, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1989
Synthetic peptide corresponding to a conserved domain of the retroviral protein p15E blocks IL-1-mediated signal transductionR A Gottlieb, W J Lennarz, R D Knowles, et al.
International Journal of Immunopathology and Pharmacology|March 10, 2007
HLA-A2.1-restricted T cells react to SEREX-defined tumor antigen CML66L and are suppressed by CD4+CD25+ regulatory T cellsY Yan, Y Chen, F Yang, et al.
DNA and Cell Biology|December 1, 1993
Cloning and genetic characterization of the human kinesin light-chain (KLC) geneY Cabeza-Arvelaiz, L C Shih, N Hardman, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1981
Human T lymphocyte/monocyte interaction in response to lectin: kinetics of entry into the S-phaseA L Maizel, S R Mehta, S Hauft, et al.
Cancer Gene Therapy|June 8, 2001
DNA vaccination against neu reduces breast cancer incidence and metastasis in miceL B Lachman, X M Rao, R H Kremer, et al.
Nature|November 19, 1981
Soluble factor activation of human B lymphocytesR J Ford, S R Mehta, D Franzini, et al.
Gene Therapy|October 7, 2006
Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasisM C Leslie, Y-J Zhao, L B Lachman, et al.
Helicobacter|February 15, 2000
Quantitation of Helicobacter pylori in the stomach using quantitative polymerase chain reaction assaysB Ozpolat, J K Actor, X M Rao, et al.
AIDS Research and Human Retroviruses|August 1, 1995
Cytokine-containing liposomes as adjuvants for HIV subunit vaccinesL B Lachman, L C Shih, X M Rao, et al.
The Journal of Experimental Medicine|October 1, 1983
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cellsE A Grimm, R J Robb, J A Roth, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1989
Synthetic peptide corresponding to a conserved domain of the retroviral protein p15E blocks IL-1-mediated signal transductionR A Gottlieb, W J Lennarz, R D Knowles, et al.
International Journal of Immunopathology and Pharmacology|March 10, 2007
HLA-A2.1-restricted T cells react to SEREX-defined tumor antigen CML66L and are suppressed by CD4+CD25+ regulatory T cellsY Yan, Y Chen, F Yang, et al.
DNA and Cell Biology|December 1, 1993
Cloning and genetic characterization of the human kinesin light-chain (KLC) geneY Cabeza-Arvelaiz, L C Shih, N Hardman, et al.
Pageof 8